Cell cycle and cancer: cycling out of contro
Abstract
Disruption in mechanisms controlling cell proliferation is a hallmark of cancer. In higher eukaryotes, cell cycle progression and cell division is driven by the sequential activation of a family of proteins called cyclin-dependent kinases (Cdks). Mutations in Cdks or in their molecular modulators have been identified in the vast majority of human tumours. However, ablation of most of these proteins in mice produces only mild phenotypes, suggesting that other compensatory mechanisms exit. Thus unveiling the molecular mechanisms that control cell cycle is fundamental in understanding the molecular basis of cancer. In this review, we will discuss cell cycle and its regulators and their role,in cancer development based on recent findings obtained using genetically modified mice. This is a review article.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Marta Puyol, Alan Seddon, Gulfaraz Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.